» Articles » PMID: 31951978

The Glittre Activities of Daily Living Test in Women with Scleroderma and Its Relation to Hand Function and Physical Capacity

Overview
Date 2020 Jan 18
PMID 31951978
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The hands are the primary site of involvement in scleroderma, and impaired hand function is primarily responsible for difficulty in performing activities of daily living. This study aimed to evaluate exercise functional capacity in women with scleroderma through the Glittre Activities of Daily Living Test, which incorporates both lower and upper limb activities, and to correlate the findings with physical capacity and hand function.

Methods: Thirty-three women with scleroderma and 30 matched control women were assessed with the Glittre Activities of Daily Living Test, the Cochin Hand Functional Scale for hand function, the Scleroderma Health Assessment Questionnaire Disability Index for physical capacity, handgrip strength tests, and pulmonary function tests.

Findings: In the Glittre Activities of Daily Living Test, the median values for total time, manual time, and the manual time/total time ratio were higher among individuals with scleroderma than among controls (P ˂ 0.001 for all tests). Manual time was significantly correlated with the Cochin Hand Functional Scale, the Scleroderma Health Assessment Questionnaire Disability Index, and handgrip strength. Additionally, peripheral oxygen saturation during the Glittre Activities of Daily Living Test was significantly correlated with pulmonary function parameters.

Interpretation: Our results indicate that women with scleroderma need more time to complete the activities in the Glittre Activities of Daily Living Test, largely due to greater difficulty performing the shelves manual task. Thus, the Glittre Activities of Daily Living Test may be used in clinical practice to evaluate the performance of activities of daily living by people with scleroderma.

Citing Articles

Reliability and validity of the Londrina activities of daily living protocol in individuals with systemic sclerosis.

Gedikli Y, Ozcan Kahraman B, Birlik M, Acar S, Savci S Clin Rheumatol. 2025; 44(2):719-726.

PMID: 39786679 PMC: 11775064. DOI: 10.1007/s10067-025-07309-y.


Changes in the Glittre-ADL test in patients with non-small cell lung cancer: Pre- and postoperative analysis after home-based rehabilitation: A preliminary study.

Ferreira I, de Almeida J, Santos M, Cruz B, Mafort T, Lopes A Heliyon. 2024; 10(23):e40646.

PMID: 39654716 PMC: 11626008. DOI: 10.1016/j.heliyon.2024.e40646.


Evaluating performance on the Glittre-ADL test in men with long COVID 3 years after a SARS-CoV-2 infection.

Silva M, Carvalho T, de Azevedo Vieira J, Costa L, da Silva D, Costa A J Exerc Sci Fit. 2024; 22(4):271-277.

PMID: 38601317 PMC: 11002684. DOI: 10.1016/j.jesf.2024.03.010.


Determinants of Six-Minute Walk Test Performance in Women with Systemic Sclerosis.

Sezgin N, Acar S, Savci S, Ozcan Kahraman B, Tanriverdi A, Koken Avsar A J Musculoskelet Neuronal Interact. 2023; 23(4):489-497.

PMID: 38037366 PMC: 10696370.


Assessment of Functional Capacity in Patients with Nondialysis-Dependent Chronic Kidney Disease with the Glittre Activities of Daily Living Test.

Balata M, Ferreira A, da Silva Sousa A, Meinertz L, de Sa L, Araujo V Healthcare (Basel). 2023; 11(12).

PMID: 37372926 PMC: 10298012. DOI: 10.3390/healthcare11121809.